Centene logged a -1.0% change during today's afternoon session, and is now trading at a price of $72.45 per share. The S&P 500 index moved 0.0%. CNC's trading volume is 904,395 compared to the stock's average volume of 3,177,607.
Centene trades -13.26% away from its average analyst target price of $83.53 per share. The 15 analysts following the stock have set target prices ranging from $72.0 to $110.0, and on average have given Centene a rating of buy.
If you are considering an investment in CNC, you'll want to know the following:
-
Centene's current price is 2.7% above its Graham number of $70.54, which implies that at its current valuation it does not offer a margin of safety
-
Centene has moved -12.0% over the last year, and the S&P 500 logged a change of 15.0%
-
Based on its trailing earnings per share of 4.51, Centene has a trailing 12 month Price to Earnings (P/E) ratio of 16.1 while the S&P 500 average is 15.97
-
CNC has a forward P/E ratio of 10.8 based on its forward 12 month price to earnings (EPS) of $6.71 per share
-
The company has a price to earnings growth (PEG) ratio of 0.86 — a number near or below 1 signifying that Centene is fairly valued compared to its estimated growth potential
-
Its Price to Book (P/B) ratio is 1.53 compared to its sector average of 4.16
-
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States.
-
Based in Saint Louis, the company has 74,300 full time employees and a market cap of $38.7 Billion.